Table 5.

Predictors of mucormycosis among patients with COVID-19 infection.

	Univarite regrssion analysis			Multivarite regrssion analysis
	OR	95% CI	P value	OR	95% CI	P value
Male sex	1.11	0.98–1.76	0.03	1.17	0.22–6.30	0.84
Diabetes mellitus	11.34	1.44–28.87	< 0.001	13.99	1.96–29.79	< 0.001
Hypertesnion	1.04	1.01–2.22	0.04	1.08	0.16–7.22	0.93
Current smoking	2.67	2.01–4.55	0.01	3.49	3.13–6.33	< 0.001
GGO	1.13	1.10–3.09	0.04	1.23	0.78–3.01	0.99
Severe infection	1.41	1.22–4.32	0.03	1.81	0.24–13.31	0.55
Anaemia	1.06	1.01–2.92	0.03	1.01	0.22–2.50	0.99
Leucouytosis	0.89	0.22–0.99	0.04	0.56	0.10–3.22	0.52
Raised ESR	1.90	1.14–2.30	0.01	2.69	1.71–4.03	0.01
Steroid dose	1.11	1.01–2.30	0.03	1.09	0.89–3.01	0.99

COVID-19: coronavirus disease 2019; CI: confidence interval; ESR: erythrocyte sedimentation rate; OR: odd’s ratio; GGO: ground glass opacity.

Significant values are given in bold.

P value was significant if < 0.05.